Stay updated on Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial

Sign up to get notified when there's something new on the Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T01:24:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1.0%
    Check dated 2025-06-19T17:21:32.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T07:38:44.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T04:58:22.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:38:57.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of a clinical study involving Nivolumab and Gemcitabine for treating Non-Small Cell Lung Cancer Stage IIIB, with specific details on the treatment regimen and study location. The previous version's detailed objectives and criteria for the study have been removed.
    Difference
    48%
    Check dated 2025-04-15T23:53:23.000Z thumbnail image

Stay in the know with updates to Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial page.